1. Home
  2. FLYX vs NSPR Comparison

FLYX vs NSPR Comparison

Compare FLYX & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo flyExclusive Inc.

FLYX

flyExclusive Inc.

HOLD

Current Price

$7.50

Market Cap

70.2M

Sector

Finance

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$1.79

Market Cap

81.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLYX
NSPR
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.2M
81.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLYX
NSPR
Price
$7.50
$1.79
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
20.1K
56.0K
Earning Date
02-22-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$362,955,000.00
$7,779,000.00
Revenue This Year
$28.47
$22.76
Revenue Next Year
$22.44
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
16.38
14.04
52 Week Low
$1.90
$1.59
52 Week High
$6.90
$3.80

Technical Indicators

Market Signals
Indicator
FLYX
NSPR
Relative Strength Index (RSI) 76.85 42.83
Support Level $3.08 $1.78
Resistance Level $4.50 $1.95
Average True Range (ATR) 0.59 0.15
MACD 0.21 -0.01
Stochastic Oscillator 71.75 29.41

Price Performance

Historical Comparison
FLYX
NSPR

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: